Orange Book product · Brand (NDA)
RIZAFILM
RIZATRIPTAN BENZOATE
At a glance
Apr 14, 2023
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 14, 2023
3 yr 3 mo ago
Today
Patent 9301948 expires
Listed drug substance patent expiration.
Jul 30, 2034
in 8 yr 3 mo
Pharmaceutical detail
Active ingredient
RIZATRIPTAN BENZOATE
Strength
EQ 10MG BASE
Dosage form
FILM
Route
ORAL
TE code
Not listed
Application
NDA 205394
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1998MAXALT-MLTBrand (NDA)
NDA 020865 · ORGANON
- 1998MAXALTBrand (NDA)
NDA 020864 · ORGANON LLC
- 2017RIZATRIPTAN BENZOATEGeneric (ANDA)
ANDA 207835 · UNICHEM
- 2017RIZATRIPTAN BENZOATEGeneric (ANDA)
ANDA 207836 · UNICHEM
- 2017RIZATRIPTAN BENZOATEGeneric (ANDA)
ANDA 204722 · PANACEA
- 2016RIZATRIPTAN BENZOATEGeneric (ANDA)
ANDA 203269 · ALKEM LABS LTD
- 2015RIZATRIPTAN BENZOATEGeneric (ANDA)
ANDA 203334 · JUBILANT GENERICS
- 2014RIZATRIPTAN BENZOATEGeneric (ANDA)
ANDA 203252 · JUBILANT GENERICS
- 2014RIZATRIPTAN BENZOATEGeneric (ANDA)
ANDA 203146 · MACLEODS PHARMS LTD
- 2014RIZATRIPTAN BENZOATEGeneric (ANDA)
ANDA 203147 · MACLEODS PHARMS LTD
- 2013RIZATRIPTAN BENZOATEGeneric (ANDA)
ANDA 204090 · AVET LIFESCIENCES
- 2013RIZATRIPTAN BENZOATEGeneric (ANDA)
ANDA 202477 · APOTEX INC
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9301948 | Jul 30, 2034 | in 8 yr 3 mo | SubstanceProduct |

